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ABSTRACT
The objective was to determine the
cardiopulmonary effects and eyeball centralization time
obtained with 15 or 30μg kg-1 of atracurium in anesthetized
dogs under spontaneous breathing. Eighteen healthy adult
mixed-breed dogs were used, which received 0.1mg kg-1
acepromazine and 0.5mg kg-1 morphine IM, followed by 4mg
kg-1 propofol IV and maintained on isoflurane anesthesia with
spontaneous breathing. Animals received 1mL 0.9% NaCl IV
(CG), 15μg kg-1 (G15) or 30μg kg-1 (G30) of atracurium IV.
Eyeball centralization time was measured; heart rate (HR),
systolic (SAP), mean (MAP) and diastolic (DAP) arterial
pressures, respiratory rate (RR), tidal volume (Vt) and minute
volume (Vm) were determined every 5min, and pH, arterial
CO2 pressure (PaCO2 ), arterial O2 pressure (PaO2 ), hemoglobinoxygen saturation (SaO2 ),
 bicarbonate (HCO3-) and base excess
(BE) every 15min until 60min. Both doses of atracurium
produced a similar period of eyeball centralization. Vt in groups
treated with atracurium was lower than in CG up to 15min. Vm
in G15 differed from CG up to 10min and in G30 up to 25min.
No differences were observed for cardiovascular parameters,
RR, SaO2, PaO2, HCO3- and BE. pH decreased in CG between
30 and 60min and in G15 and G30 at 15min. G30 differed
from CG between 15 and 30min. PaCO2 in GC differed from
baseline between 30 and 60min and in G15 differed at 15min.
Atracurium at the dose of 15μg kg-1 is adequate for short corneal
procedures in inhalant-anesthetized dogs under spontaneous
breathing.
Key words: dog, atracurium, spontaneous breathing, corneal
ulcer.
RESUMO
Objetivou-se determinar os efeitos
cardiopulmonares e o tempo de centralização do globo ocular
obtidos com 15 ou 30μg kg-1 de atracúrio em cães anestesiados
sob ventilação espontânea. Dezoito cães adultos foram pré-
medicados com 0,1mg kg-1 de acepromazina e 0,5mg kg-1 de
morfina IM, anestesiados com 4mg kg-1 de propofol IV e
mantidos sob anestesia inalatória com isofluorano em
ventilação espontânea. Os animais receberam 1mL de NaCl
0,9% IV (GC), 15μg kg-1 (G15) ou 30μg kg-1 de atracúrio IV.
Mensuraram-se o tempo de centralização do globo ocular, a
frequência cardíaca (FC), as pressões arteriais sistólica (PAS),
média (PAM) e diastólica (PAD), a frequência respiratória (f),
o volume corrente (Vt) e o volume minuto (Vm) a cada 5min,
e o pH, as pressões arteriais de CO2 (PaCO2) e O2 (PaO2), a
saturação de oxigênio nas hemoglobinas (SaO2), 
o bicarbonato
(HCO3-) e o excesso de base (BE) a cada 15min, até 60min.
Ambas as doses de atracúrio produziram similar período de
centralização. Os grupos tratados com atracúrio apresentaram
menores valores para Vt até 15min. O Vm, no G15, diferiu do
GC até 10min e do G30 até 25min. Não foram observadas
alterações nos parâmetros cardiovasculares f, SaO2, PaO2,
HCO3- e EB. O pH diminuiu no GC entre 30 e 60min e em G15
e G30 aos 15min. A PaCO2 elevou-se no GC entre 30 e 60min e no
G15 aos 15min. A dose de 15μg kg-1 de atracúrio demonstrou ser
adequada para centralização do globo ocular, podendo ser utilizada
em procedimentos corneanos de curta duração em cães
anestesiados com isoflurano e mantidos sob ventilação espontânea.
Palavras-chave: cão, atracúrio, ventilação espontânea, úlcera
corneana.
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INTRODUCTION
Neuromuscular blocking agents are
commonly utilized as adjuvants to general anesthetics
to facilitate ventilation, and in thoracic, orthopedic and
intraocular surgeries, in this case to produce
centralization of the eyeball (GLOVER &
CONSTANTINESCU, 1997), keeping the cornea totally
visible and thereby facilitating surgical procedures.
However, there is the need of artificial ventilation due
to respiratory paralysis.
The action of neuromuscular blocking
agents is characterized by flaccid paralysis obtained at
different speeds, depending on the body region.
Generally, the oculomotor muscles are affected first,
followed by the tail, oropharynx and limbs. The
intercostals, diaphragm and abdominal muscles are the
last ones to follow the sequence of paralysis. In
summary, there is a progressive blockade, from the
periphery to the center, where recovery occurs in
reverse (HEMMERLING & DONATI, 2003).
The choice of low doses of neuromuscular
blockers has advantages if a selective paralysis could
be achieved, permitting adequate ventilation while the
eye is centralized (CARREGARO et al., 2006). This
facilitates the performance of intraocular surgeries and
diminishes risks to the anesthetized patient. Animals
anesthetized on spontaneous breathing maintain
cardiovascular function at better baselines than
animals on controlled ventilation (HARTSFIELD, 1996),
the latter impeding venous return to the right side of
the heart, reducing cardiac output and arterial pressure.
Besides, the procedure is less expensive because there
is no need for specific equipment for the maintenance
of ventilation.
Studies have demonstrated the possibility
of utilizing low doses of neuromuscular blockers and
maintenance of pulmonary function. In the analysis of
respiratory depression and muscle relaxation in dogs
treated with 10μg kg-1 of pancuronium, eyeball
centralization was achieved with moderate respiratory
depression without however causing apnea and without
the need for controlled ventilation in these animals (LEE
et al., 1998).
Atracurium at a dose of 250μg kg-1 causes
total muscle blockade of 15-35min of duration with
minimal cardiovascular effects (HUGHES & CHAPPLE,
1981). In a preliminary study (CARREGARO et al.,
2006), three doses of atracurium (25, 50 and 75μg kg-1)
were tested and found to cause eyeball centralization
without complete blockade of the intercostal and
diaphragmatic muscles. The time of centralization
increased with dose, that was 38, 65 and 78min,
respectively. However, there was an increase in end
tidal CO
2
 (ETCO
2
) in the 50μg kg-1 group for 5min with
a peak near 50mmHg, and a stronger effect in the 75μg
kg-1 group, with values almost as high as 60mmHg for
20min. The highly elevated ETCO
2
 values obtained
indicated a blood gas analysis for the adequate
determination of these values.
The aim of this study was to determine the
effects of 15 or 30μg kg-1 of atracurium on
cardiopulmonary parameters and on the duration of
eyeball centralization of anesthetized dogs under
spontaneous breathing.
MATERIALS   AND   METHODS
For the study proposed, 18 mixed-breed
dogs were utilized, 8 males and 10 females. The animals
were considered healthy after performing clinical and
ophthalmologic exam and laboratory tests (hemogram,
urea, creatinine, alkaline phosphatase and alanine
aminotransferase).
After 12h solid and 4h liquid fasting, animals
were pre-medicated with 0.1mg kg-1 acepromazinea and
0.5mg kg-1 morphineb IM. After 15min, the arms were
shaven, and cephalic venopuncture was performed by
a 22G catheter, which 0.9% NaCl was administered at a
rate of 10mL kg h-1 during the whole period of evaluation.
Later, the animals were anesthetized with 4mg kg-1
propofolc IV, intubated with an orotracheal tube of
suitable diameter and maintained under inhalant
anesthesia with isofluraned in 1L min-1 of 100% O
2
 in a
circular valvular circuit. The animals were positioned
in sternal recumbency during the period of evaluation.
By controlling vaporization, the animals were
maintained in stage III/2 of anesthesia, characterized
mainly by the total rotation of the eyeball and by the
presence of the slight palpebral reflex (MOENS &
COPPENS, 2007), which requires a vaporization of 1 to
1.5%. Immediately after the establishment of inhalant
anesthesia, instrumentation of the animals was initiated.
The right podal dorsal artery was
catheterized using a 22G catheter. This was connected
to a 3-way stopcock and a pressure transducer filled
with heparinized solution, positioned and zeroed at the
level of the heart to measure mean arterial pressure
(MAP), systolic arterial pressure (SAP) and diastolic
arterial pressure (DAP), in mmHg. The electrodes were
positioned in the axillary and the groin regions to
determine heart rate (HR) in beats per minute (bpm)
and rhythm, based on lead II. Cardiovascular
parameters were evaluated by a multiparametric
monitore.
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The ventilometerf was connected to the
tracheal tube, to measure tidal volume (Vt) and minute
volume (Vm), in mL. The respiratory rate (RR) was
measured by visualization of the reservoir bag, in
breaths per minute (bpm). Body temperature (T°C) was
maintained between 36 and 37ºC for the whole period
of evaluation with the aid of a thermal mattress.
After the 30min period for instrumentation
and stabilization of the vaporization and physiological
parameters, the animals were randomized and equally
assigned to one of three treatments (n=6): control (CG)
with the administration 1mL 0.9% NaCl IV; and two
with atracuriumg at 15μg kg-1 (G15) and 30μg kg-1 (G30)
IV, diluted in 0.9% NaCl and standardized to a final
volume of 1mL. The animals in G15 and G30 were
submitted to a surgical procedure for establishing a
corneal ulcer model as a part of a different research. In
the CG animals, it was not possible to carry out the
same surgical procedure since centralization of the
eyeball was not achieved.
The physiological parameters were
measured by two observers blinded to the treatments.
HR, RR, MAP, SAP, DAP, Vt, and Vm were determined
immediately before the administration of atracurium
(time 0) and every 5min after the administration of the
treatment up to 60min. Blood gas analysis was
performed at time 0 and every 15min of evaluation.
Blood samples (1mL) were anaerobically drawn with a
previously heparinized syringe from the podal dorsal
artery with the help of a 3-way stopcock connected to
the catheter, discarding the first milliliter with another
syringe. Arterial CO
2 
pressure (PaCO
2
), arterial O
2
pressure (PaO2), pH, bicarbonate (HCO3
-), bases excess
(BE) and hemoglobin oxygen saturation (SaO
2
) were
obtained immediately after the collection. The eyeball
centralization time was determined as the time from
initial centralization of the eyeball (after the
administration of atracurium) until the eyeball became
semi-rotated. At the end of the evaluation period, 0.2mg
kg-1 meloxicamh SC was administered to provide
postoperative analgesia.
Statistical analysis was performed using the
GraphPad Prism 4 programi. Repeated measure analysis
of variance (ANOVA) was used followed by Bonferroni
test for comparisons of means within each group in
relation to time zero. For comparison between groups,
at each time, one-way ANOVA was performed followed
by Tukey’s test if necessary. For comparisons regarding
the time of eyeball centralization, ordinary ANOVA was
utilized, followed by the Kruskal-Wallis test. The
differences were considered significant when P<0.05.
The parametric results are expressed as means ±
standard deviation and the non-parametric as medians
and interquartile ranges.
RESULTS
There was no difference in body weight
between groups, which CG, G15 and G30 obtained
weight of 14.8±2.2kg, 14.5±3.1kg and 14.0±3.1kg,
respectively. Eyeball centralization was observed in all
the animals of the groups treated with atracurium. There
was no significant difference between G15 and G30,
where median and interquartile range (IQR) of
neuromuscular blockade was 42.5 (10, 60) and 47.5 (20,
60) min, respectively (Figure 1). Both groups differed
significantly from CG, which did not show eyeball
centralization at any moment.
In relation to the cardiovascular parameters,
there were no differences between the groups at any
moment, or any group compared to time zero (Figure
2). In addition, no alterations in heart rhythm were
observed in any group. There was no statistical
difference between groups or in each group when
compared to basal levels for RR (Figure 2) and SaO
2
(Table 1). Vt in G15 and G30 were statistically lower
than in CG up to 15min after drug administration (Figure
2). Similarly, both groups showed a decline in Vt in
relation to their baseline values up to 10min. In the
analysis of Vm (Figure 2), G15 differed from CG up to
10min and G30 differed from CG up to 25min of
evaluation. Both groups differed from zero moment
only at 5min.
With regard to pH, there was a decrease in
relation to baseline values in CG between 30 and 60min
and in G15 and G30, only at 15min (Table 1). G30 also
differed from CG at 15 and 30min. In relation to baseline
values of PaCO
2
 (Table 1), CG differed between 30 and
60min and G15 differed at 15min. PaO
2
, bicarbonate and
Figure 1 - Time of the eyeball centralization in dogs
maintained on isoflurane anesthesia under
spontaneous breathing, treated with saline (CG),
15μg kg-1 of atracurium (G15) or 30μg kg-1 of
atracurium (G30). The boxes represent the
interquartile range, and the solid line into the
box is the median (P<0.05).
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Figure 2 - Cardiorrespiratory parameters (mean ± error deviation) evaluated in dogs (n=6 each group)
maintained on isoflurane anesthesia under spontaneous breathing, treated with saline (CG),
15μg kg-1 of atracurium (G15) or 30μg kg-1 of atracurium (G30). * Statistical difference in
relation to time 0 (P<0.05). ° Statistical difference from CG (P < 0.05). (HR – heart rate; SAP
– systolic arterial pressure; MAP – mean arterial pressure; DAP – diastolic arterial pressure; Vt
– tidal volume; Vm – minute volume; RR – respiratory rate).
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EB showed no differences in any group, in baseline
evaluation as well as after the treatments (Table 1).
DISCUSSION
The doses of atracurium utilized were
effective in blocking the extrinsic muscles of the eyeball,
causing total exposure of the cornea for an adequate
period. Because of the time obtained (42.5 and 47.5min),
these doses make it possible to carry out various
ophthalmic surgeries. The fact that no eyeball
centralization occurred in CG demonstrates that
centralization requires exclusively the use of a
peripheral muscle relaxant, but it can be intensified by
the concomitant use of inhalat anesthesia (KASTRUP
et al., 2005).
Cardiovascular parameters were maintained
within the physiological range. Atracurium causes
alterations in these parameters only at high doses,
potentially leading to hypotension and tachycardia,
due to the release of histamine (MARTINEZ, 1999).
Furthermore, neuromuscular blockers cause
tachycardia due to an antivagal action (STENLAKE &
HUGHES, 1987), but atracurium produces greater
cardiovascular stability when compared to other
blockers (HACKETT et al., 1989).
In relation to SaO
2
, all animals showed
values over 97%. This parameter does not represent
the quantity of O
2
 available to tissues, but permits the
determination of arterial oxygenation, which is
indicative of alterations that can cause risk of hypoxia
for the patient (JONES, 1996). There was no hypoxemia
associated with any of the groups studied because the
animals were supplemented with 100% oxygen, besides
being healthy and without any lung pathology.
PaO
2
 supplies information on the efficacy
of oxygenation of the lungs (HASKINS, 1996). Despite
there being no statistical difference among the groups
studied in relation to PaO
2
, CG showed at all times lower
values than those considered normal for dogs submitted
to inhalant anesthesia in 100% O
2
 with spontaneous
breathing (McDONELL, 1996). The groups treated with
atracurium showed physiologic levels or very close,
as it is anticipated in healthy subjects.
Table 1 - Blood gas parameters (mean ± standard deviation) evaluated in dogs (n = 6 each group) maintained on isoflurane anesthesia under
spontaneous breathing, treated with saline (CG), 15μg kg-1 of atracurium (G15) or 30μg kg-1 of atracurium (G30).
---------------------------------------------------------Time (min) ---------------------------------------------------------
Parameter
Group 0 15 30 45 60
CG 7.29 ± 0.03 7.27 ± 0.03 7.26 ± 0.03* 7.26 ± 0.03* 7.25 ± 0.02*
G15 7.25 ± 0.05 7.17 ± 0.13* 7.23 ± 0.06 7.23 ± 0.04 7.24 ± 0.05pH
G30 7.23 ± 0.08 7.11 ± 0.13*° 7.13 ± 0.14° 7.12 ± 0.17 7.18 ± 0.08
CG 376 ± 50 403 ± 48 402 ± 43 419 ± 27 426 ± 47
G15 446 ± 83 427 ± 75 467 ± 96 489 ± 89 442 ± 68PaO2(mmHg)
G30 431 ± 46 478 ± 22 486 ± 48 479 ± 48 504 ± 35
CG 45 ± 4 48 ± 4 49 ± 4* 49 ± 5* 50 ± 3*
G15 51 ± 7 58 ± 10* 54 ± 7 54 ± 6 53 ± 8PaCO2(mmHg)
G30 53 ± 10 73 ± 23 63 ± 16 68 ± 24 67 ± 19
CG 21.3 ± 1 21.6 ± 1 21.9 ± 1.2 21.6 ± 1.4 21.7 ± 1.3
G15 22.1 ± 1.5 22.9 ± 1.6 22.2 ± 0.9 22.2 ± 1.1 22.2 ± 1.2HCO3
-
(mmol L-1)
G30 23.3 ± 2.5 24.9 ± 3.7 24.1 ± 3.3 24.9 ± 3.9 23.9 ± 2.3
CG 98 ± 1 99 ± 0.6 99 ± 0.5 99 ± 0.4 98 ± 1
G15 98 ± 1 98 ± 1 98 ± 0.4 99 ± 0.3 97 ± 0.7SaO2(%)
G30 98 ± 1 99 ± 0.3 99 ± 0.3 99 ± 0.3 99 ± 0.2
GC -5.2 ± 0.9 -5.6 ± 1 -5.4 ± 1 -5.7 ± 1.2 -5.5 ± 1.2
G15 -5.1 ± 1.7 -6.2 ± 2.4 -5.6 ± 1.5 -5.6 ± 1.2 -5.3 ± 1.2BE
G30 -4.75 ± 1.7 -6 ± 1.2 -6.5 ± 1.6 -6 ± 1.3 -5.1 ± 1
* Statistical difference in relation to time 0 (P<0.05).
°   Statistical difference from CG (P<0.05).
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Vt was lower up to 15min in the groups
treated with atracurium, when compared to CG, but
considering the physiologic range, which is 10 to 20mL
kg-1 (HASKINS, 1996), this variable showed a decline
in G30 from 5 to 45min and in G15 only up to 15min.
Since there was a reduction in Vm without occurrence
of bradypnea in animals treated with atracurium, mainly
in G30, a decrease in respiratory amplitude occurred,
with consequent hypercapnia and decrease in pH.
Since CO
2
 diffuses easily through alveolar
capillaries, the alveolar CO2 tension and PaCO2 are
essentially the same. As a result, the measure of PaCO
2
provides direct information on the sufficiency of
alveolar ventilation (DIBARTOLA & MORAIS, 1992).
Despite that the PaCO
2
 values were higher than
physiological levels in all the groups evaluated, there
was no significant difference between them, indicating
that the administration of atracurium was not the only
cause of the elevation of this parameter. Elevated PaCO
2
caused a reduction in pH, and clinical acidosis was
observed in all groups, including CG. The results
observed in G15 showed acidosis only up to 15min,
being equal to CG after on. Those values demonstrate
that the inhalant procedure was the most important
cause for the acidosis. Inhalant anesthesia is one of
the most common causes of respiratory acidosis
(ROBERTSON, 1989; MUTOH et al., 1997), that can
increase the action of peripheral muscle relaxants (ONO
et al., 1988).
It should be pointed out that, although the
use of atracurium at low doses does not cause apnea,
the reversal of the blockade after doing the procedure
is recommended, since the oropharynx muscles are
blocked subsequently as the oculomotor muscles,
which is associated with an increased risk of aspiration
pneumonia. Moreover, the residual neuromuscular
blockade is frequently observed after the end of general
anesthesia, impairing the recovery of the patient
(MURPHY, 2006). Also, the use of controlled or assisted
ventilation and monitoring with Train of Four must be
considered, to make procedures which use
neuromuscular blockers safer.
CONCLUSION
Both doses of atracurium produced a similar
period of eyeball centralization without cardiovascular
alterations and bradypnea, but with respiratory
acidosis. We suggest that the dose of 15μg kg-1 of
atracurium is adequate for short corneal procedures in
inhalant-anesthetized dogs under spontaneous
breathing.
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